(Q28251373)

English

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer

scientific article

Statements

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer (English)
0 references
0 references
Stephen R Wedge
0 references
Jane Kendrew
0 references
Laurent F Hennequin
0 references
Paula J Valentine
0 references
Simon T Barry
0 references
Sandra R Brave
0 references
Neil R Smith
0 references
Neil H James
0 references
Michael Dukes
0 references
Jon O Curwen
0 references
Rosemary Chester
0 references
Janet A Jackson
0 references
Sarah J Boffey
0 references
Lyndsey L Kilburn
0 references
Sharon Barnett
0 references
Graham H P Richmond
0 references
Peter F Wadsworth
0 references
Mike Walker
0 references
Alison L Bigley
0 references
Sian T Taylor
0 references
Lee Cooper
0 references
Sarah Beck
0 references
Juliane M Jürgensmeier
0 references
Donald J Ogilvie
0 references
15 May 2005
0 references
65
0 references
10
0 references
4389-400
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit